{
    "eid": "2-s2.0-85099736586",
    "title": "Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Chronic kidney disease",
        "Indoxyl sulfate",
        "p-Cresyl sulfate",
        "Protein-bound uremic toxins"
    ],
    "authors": [
        "Kullaya Takkavatakarn",
        "Thunyatorn Wuttiputinun",
        "Jeerath Phannajit",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong",
        "Paweena Susantitaphong"
    ],
    "citedby-count": 15,
    "ref-count": 65,
    "ref-list": [
        "Role of uremic toxins for kidney, cardiovascular, and bone dysfunction",
        "Review on uremic toxins: Classification, concentration, and interindividual variability",
        "Intensive hemodialysis fails to reduce plasma levels of uremic solutes",
        "Protein-bound uremic toxins: A long overlooked culprit in cardiorenal syndrome",
        "The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism",
        "Uremic toxins originating from colonic microbial metabolism",
        "Indoxyl sulfate is a nephro-vascular toxin",
        "P-cresyl sulfate",
        "Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate",
        "Meta-analysis of the associations of p-cresyl sulfate (p-cresyl sulfate) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure",
        "Indoxyl sulfate: A novel cardiovascular risk factor in chronic kidney disease",
        "The uremic retention solute p-cresyl sulfate and markers of endothelial damage",
        "The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration",
        "Assessing the quality of randomized trials: Reliability of the Jadad scale",
        "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses",
        "Assessing heterogeneity in meta-analysis: Q statistic or i2 index?",
        "Bias in meta-analysis detected by a simple, graphical test",
        "Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease",
        "Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (MEDIKA study)",
        "Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in non-dialysis chronic kidney disease patients?",
        "P-cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin",
        "Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients",
        "Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial",
        "Effects of fermentable high fiber diet supplementation on gut derived and conventional nitrogenous product in patients on maintenance hemodialysis: A randomized controlled trial",
        "Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis",
        "Mp431effects of probiotic supplementation on uremic toxins levels in non-dialysis CKD patients",
        "Probiotic supplementation in chronic kidney disease: A double-blind, randomized, placebo-controlled trial",
        "Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: A preliminary study",
        "Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial",
        "Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients",
        "Effect of probiotics on serum indoxyl sulphate in haemodialysis patients",
        "The effect of synbiotics on serum indoxyl sulfate in maintenance haemodialysis patients",
        "Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial",
        "Accumulation of indoxyl-beta-d-glucuronide in uremic serum: Suppression of its production by oral sorbent and efficient removal by hemodialysis",
        "Carbonic-adsorbent ast-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure",
        "A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of ast-120 (kremezin) in patients with moderate to severe ckd",
        "Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients",
        "Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on stage 5 chronic kidney disease patients: A randomized crossover study",
        "A randomized, controlled trial of oral intestinal sorbent AST-120 on renal function deterioration in patients with advanced renal dysfunction",
        "Effects of chitosan on oxidative stress and related factors in hemodialysis patients",
        "Shen-shuai-ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis",
        "Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: Evidence from a randomized controlled trial",
        "Does the administration of sevelamer or nicotinamide modify uremic toxins or endotoxemia in chronic hemodialysis patients?",
        "Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration",
        "Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration",
        "Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: Results from the redert study",
        "Fp438study of the effects of hemodiafiltration versus hemodialysis on DNA methylation and indoxyl sulfate removal",
        "Differences in dialysis efficacy have limited effects on protein-bound uremic toxins plasma levels over time",
        "Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis",
        "Adsorption of protein-bound uremic toxins through direct hemoperfusion with hexadecyl-immobilized cellulose beads in patients undergoing hemodialysis",
        "Indoxyl sulfate elimination in renal replacement therapy: Influence of citrate- versus acetate-buffering component during bicarbonate dialysis",
        "Sp366effects of citrate dialysis fluid on cell damage, uremic toxin, and inflammation in patients with maintenance hemodialysis",
        "Daytime rhythm and treatment-related fluctuations of serum phosphorus concentration in dialysis patients",
        "Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients",
        "Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population",
        "Dietary protein intake and chronic kidney disease",
        "The effects of restricted protein diet supplemented with ketoanalogue on renal function, blood pressure, nutritional status, and chronic kidney disease-mineral and bone disorder in chronic kidney disease patients: A systematic review and meta-analysis",
        "Probiotics and chronic kidney disease",
        "Probiotic formulations: Application and status as pharmaceuticals-a review",
        "Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: A systematic review and meta-analysis",
        "Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: The nature, mechanisms, consequences and potential treatment",
        "Review of the efficacy of ast-120 (kremezin) on renal function in chronic kidney disease patients",
        "Effects and safety of an oral adsorbent on chronic kidney disease progression: A systematic review and meta-analysis",
        "Clinical evidence on haemodiafiltration",
        "Benefits of preserving residual renal function in peritoneal dialysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}